Back
Janux Therapeutics Stock Price Chart
![](/images/offers/ims/large/offer4.jpg)
$1,300 into $45,000 in just 4 MONTHS?!
See here to see the full details.
Sell
44
JANX
Janux Therapeutics
Last Price:
44.05
Seasonality Move:
-18.02%
7 Day Trial
ALL ACCESS PASS
$
7
![](/images/offers/ims/large/offer5.jpg)
Groundbreaking AI Developed In Small Georgia Town Destroys Wall Street
See the remarkable discovery.- The current trend is moderately bullish and JANX is experiencing selling pressure, which indicates risk of future bearish movement.
Janux Therapeutics Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 44.91 | Sell |
20-day SMA: | 42.68 | Buy |
50-day SMA: | 44.11 | Sell |
200-day SMA: | 27.77 | Buy |
8-day EMA: | 44.37 | Sell |
20-day EMA: | 43.63 | Sell |
50-day EMA: | 43.64 | Sell |
200-day EMA: | 32.85 | Buy |
Janux Therapeutics Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.42 | Buy |
Relative Strength Index (14 RSI): | 47.92 | Sell |
Chaikin Money Flow: | -379974 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (40.04 - 44.7) | Buy |
Bollinger Bands (100): | (38.61 - 51.05) | Sell |
Janux Therapeutics Technical Analysis
Jul 12 | Jul 15 | Jul 16 | Jul 17 | Jul 18 | Jul 19 | Jul 22 | Jul 23 | Jul 24 | Jul 25 | |
---|---|---|---|---|---|---|---|---|---|---|
Jul | ||||||||||
12 | 15 | 16 | 17 | 18 | 19 | 22 | 23 | 24 | 25 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Janux Therapeutics Stock
Is Janux Therapeutics Stock a Buy?
- Janux Therapeutics share price is 42.76 while JANX 8-day simple moving average is 44.91, which is a Sell signal.
- The stock price of JANX is 42.76 while Janux Therapeutics 20-day SMA is 42.68, which makes it a Buy.
- Janux Therapeutics 50-day simple moving average is 44.11 while JANX share price is 42.76, making it a Sell technically.
- JANX stock price is 42.76 and Janux Therapeutics 200-day simple moving average is 27.77, creating a Buy signal.
JANX Technical Analysis vs Fundamental Analysis
Sell
44
Janux Therapeutics (JANX)
is a Sell
Is Janux Therapeutics a Buy or a Sell?
-
Janux Therapeutics stock is rated a Sell
The current Janux Therapeutics [JANX] share price is $42.76. The Score for JANX is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.
Janux Therapeutics Stock Info
Market Cap:
2.22B
Price in USD:
42.76
Share Volume:
392.26K
Janux Therapeutics 52-Week Range
52-Week High:
65.60
52-Week Low:
5.65
Sell
44
Janux Therapeutics (JANX)
is a Sell
Janux Therapeutics Share Price Forecast
-
What is the Janux Therapeutics stock price today?
The Janux Therapeutics stock price is 42.76 USD today. -
Will JANX stock go up or go down?
Janux Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Janux Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Janux Therapeutics is overvalued.
Is Janux Therapeutics Stock a Buy?
- Janux Therapeutics share price is 42.76 while JANX 8-day exponential moving average is 44.37, which is a Sell signal.
- The stock price of JANX is 42.76 while Janux Therapeutics 20-day EMA is 43.63, which makes it a Sell.
- Janux Therapeutics 50-day exponential moving average is 43.64 while JANX share price is 42.76, making it a Sell technically.
- JANX stock price is 42.76 and Janux Therapeutics 200-day simple moving average is 32.85, creating a Buy signal.
Fundamental Analysis of Janux Therapeutics
Is Janux Therapeutics a good investment?
- Analysts estimate an earnings increase this quarter of $0.12 per share, an increase next quarter of $0.06 per share, an increase this year of $0.11 per share, and a decrease next year of $0.39 per share.
Technical Analysis of Janux Therapeutics
Should I short Janux Therapeutics stock?
- JANX Moving Average Covergence Divergence (MACD) indicator is 0.42, suggesting Janux Therapeutics is a Buy
- Janux Therapeutics Relative Strength Index (RSI) is 47.92, which suggest Janux Therapeutics is oversold
- The Bollinger Bands (25) for Janux Therapeutics is (40.04 - 44.7), which suggest Janux Therapeutics is a Sell
- The Bollinger Bands (100) for Janux Therapeutics is (38.61 - 51.05), which suggest Janux Therapeutics is a Sell
* Janux Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.